Dhanuka Laboratories

Dhanuka Laboratories operates through Dhanuka Laboratories Limited (active). Its filings, financials, charges and directors are on the company page.

Last known valuation $27.29M (Mar 2020). 7 investors in total: 2 institutional and 5 angel.

Dhanuka Laboratories has secured backing from 7 investors, including institutional and angel investors. Prominent investors backing the company include Triveni Memorial Educational Trust, Manish Dhanuka and Arun Kumar Dhanuka.

All

Institutional

Angel

Investor	Description	Founded Year	Domain	Location
Triveni Memorial Educational Trust	Provides comprehensive education solutions for kindergarten and high school students.	2001	trivenitrust.com	Bengaluru, India
Pushpa Dhanuka Trust
MD Manish Dhanuka			unknown_d6abfb8d8c694b769
AK Arun Kumar Dhanuka			unknown_34f2d90aea814c098
AD Arjun Dhanuka			unknown_eb46867c2fcf4b87b
MD Manas Dhanuka			unknown_453d53043cae46ed9
SD Seema Dhanuka			unknown_835981fee6484fac9

Premium access

Investor details for Dhanuka Laboratories

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

• Complete investor list
• Round participation
• Investor portfolios
• Co-investor network

Access investors

Verified entity values are shown only after access is granted.

Dhanuka Laboratories Limited is the primary company behind Dhanuka Laboratories. The board of Dhanuka Laboratories Limited currently have 9 directors; the longest-serving is Manish Dhanuka, appointed in 1993. 16 earlier directors have ceased.

2 people are tracked at Dhanuka Laboratories (2 in leadership); the tracked headcount is 583.

Figures of Dhanuka Laboratories Limited, the primary company behind Dhanuka Laboratories, for FY 2025. Revenue was ₹1,424 Cr (-3% year on year). Net profit was ₹123 Cr (9% margin). EBITDA was ₹181 Cr (13% margin). Revenue has grown at a compounded annual rate of +8% over three years and +28% over five years.

• ₹1,424 CrRevenue · FY 2025 · -3% YoY
• ₹123 CrNet profit · 9% margin
• ₹181 CrEBITDA · 13% margin
• ₹13.85 CrPaid-up capital
• 583Employees (provident fund records)
• +8%Revenue CAGR, 3 years
• +28%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Dhanuka Laboratories Limited are on its company page.

Dhanuka Laboratories has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Orchid Pharma.

5 dated milestones of Dhanuka Laboratories across 22 years, from founding to its latest funding, stage changes and deals.

1. 1998 Founded Dhanuka Laboratories is founded.
2. Mar 2019 Funding First funding round of $2.2M.
3. Mar 2019 Milestone Reaches Minicorn status.
4. Jul 2019 Acquisition Acquires Orchid Pharma.
5. Mar 2020 Funding Latest funding round, Unspecified, of $5.3M.

3 companies that operate in the same segment as Dhanuka Laboratories (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.

Company	Description	Founded	Location	Total funding	Revenue	Employees
Inventia Healthcare	Oral solid drug delivery systems are manufactured and developed.	1985	Mumbai, Maharashtra, India	USD 42.49 M	USD 89.42 M	962
Strides Pharma Science	Generic, semi-solid, and liquid dosage forms are manufactured.	1990	Bengaluru, Karnataka, India		USD 508.93 M	5,180
Sun Pharma	Specialty generic pharmaceuticals and APIs are manufactured and marketed.	1983	Mumbai, Maharashtra, India		USD 6.21 B	25,870